Time to read: 04:58. Adding weekly cisplatin to adjuvant radiotherapy in intermediate-risk early-stage cervical cancer following radical hysterectomy failed to significantly improve recurrence-free survival (88.5% vs 85.4%, p=0.09) or overall survival (97.2% vs 90.3%, p=0.07) whilst significantly increasing grade 3-4 toxicities (43% vs 15%).

Source: ESMO Annals of Oncology

Feature Text

Time to read: 04:23.In this study, researchers evaluated the adoption of surgical de-escalation techniques in the field of gynaecologic oncology using data from The National Cancer Database (NCDB). A broader understanding of these trends will provide insights into the adoption and effectiveness of de-escalation strategies, paving the way for future research to enhance patient care.

Source: JAMA Network Open

Text

Time to read: 05:43. The study aimed to investigate the potential of cfDNA-sequencing results, specifically when unusual or non-reportable, as indicators of undiagnosed cancer in pregnant and post-partum individuals.

Source: NEJM

Text